Trials / Completed
CompletedNCT01053897
Study of GBT009 for Treatment of Incisional Wounds Following Breast Reconstruction Surgery
A Phase 2, Multicenter, Double-Blind, Placebo-Controlled Study of GBT009 for Treatment of Incisional Wounds Following Breast Reconstruction Surgery
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- Garnet BioTherapeutics, Inc. · Industry
- Sex
- Female
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to assess whether intradermal injections of GBT009 along full thickness incisions following surgery results in an improvement in scar appearance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | GBT009 | Intradermal Injection following surgery |
| BIOLOGICAL | Placebo | Intradermal Injection following surgery |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2011-10-01
- Completion
- 2011-10-01
- First posted
- 2010-01-22
- Last updated
- 2013-10-24
- Results posted
- 2013-10-24
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01053897. Inclusion in this directory is not an endorsement.